The hit 1979 film Norma Rae could be headed to the stage. A musical adaptation is in the works featuring a score composed by Grammy winner Rosanne Cash, according to a story in The New York Daily News.Norma Rae follows a factory worker in North Carolina who begins involvement in labor union activities after her health and that of her colleagues at a textile factory is compromised. The film features an Oscar-nominated screenplay by Irving Ravetch and Harriet Frank Jr. and an Oscar-winning performance from Sally Field in the title role.Rosanne Cash is a four-time Grammy-winning singer-songwriter. The potential Norma Rae musical would be her first foray into musical theater. Cash is the oldest daughter of country music star Johnny Cash, whose music was adapted into the 2006 Broadway musical Ring of Fire.Additional creative team members for the Norma Rae musical is currently unknown, nor is a development timeline yet in place. View Comments Sally Field in the film “Norma Rae”(Photo: Twentieth Century Fox)
Overland Park Police are looking for the one of three men associated with an early morning burglary.Overland Park police this afternoon issued a release about an early morning burglary in the 8700 block of Nieman:The Overland Park Police Department needs your assistance in identifying one of three burglars. The burglary occurred in the 8700 Nieman in the early morning hours on June 16th, 2017. The suspect arrived in a small black SUV. During the burglary, the ATM machine was taken from the scene. The business was able obtain a photo of one of the suspects. Anyone with information on this crime is asked to contact the Overland Park Police Department at 913-344-8732 or the TIPS HOTLINE at 816-474-TIPS.
Sep 27, 2012 (CIDRAP News) – British health officials said today that a Rotterdam lab that first characterized the novel coronavirus linked recently to two severe illnesses hopes to publish the whole genome in the next 24 to 48 hours, and the UK’s Health Protection Agency (HPA) launched guidance to help clinicians investigate and manage possible cases.The HPA said in an update that the full genome sequence will be published by Ron Fouchier, PhD, based at Erasmus University in the Netherlands. The sequence will be based on cultured virus that has been at the lab since early July.Yesterday the agency gave the same time frame for release of the full sequence and did not change the estimate in today’s update.The HPA had earlier released the partial sequence for the virus’s polymerase gene, obtained from an infected patient undergoing treatment in London, which enabled scientists to compare it with others and determine that the new virus is related to bat coronaviruses. The HPA said it doesn’t yet have a viral isolate, but clinical material from the patient is being cultured to make isolates.Also, the HPA shared new details about molecular diagnostics for identifying the new virus. It said pan-coronavirus primers described by an international group of researchers in 2003 and in a 2008 report from Belgian researchers should both be useful. However, the clinical material the HPA has does not react with specific assays it has for OC23, 229E, NL64, or SARS. It said it welcomed offers of reagents and information from scientists who specialize in the area.In other developments, the HPA published some clinical tools to help clinicians manage suspected and confirmed cases along with close contacts. The tools include an algorithm for investigating and managing possible cases; it describes the testing process, protective actions to take if an infection is confirmed, and the next steps to take for sample collection and data reporting.Another algorithm walks clinicians through investigating close contacts of patients with confirmed novel coronavirus infections. For contacts who don’t have clinical symptoms during the initial visit, the HPA recommends that baseline clotted blood samples be taken as soon as possible, ideally no later than 7 days after exposure. The algorithm recommends that follow-up samples be taken at least 14 days after baseline or 28 days after exposure if a sample couldn’t be taken when the case-patient was asymptomatic. It says a contact form should be completed 10 days after the initial data is collected.The HPA also issued a nine-page infection control resource for handling confirmed and suspected cases. It noted that coronaviruses are mainly transmitted by large respiratory droplets and direct or indirect contact with secretions. The agency also said the viruses can be detected in feces and urine and in some instances can be transmitted by aerosolized respiratory droplets and feces. It detailed steps to take in addition to standard precautions, such as what type of respirator and personal protective equipment (PPE) to use.In developments elsewhere, Hong Kong’s Centre for Health Protection (CHP) said today that the process to make novel coronavirus infection a notifiable disease is under way. It said a legislative amendment will be recorded tomorrow, taking effect immediately. Health practitioners will be required to notify the CHP’s director of health if they suspect the disease, and labs will be required to report virus leaks that may pose a public health risk.No new infections involving the novel coronavirus have been detected beyond the Qatari man hospitalized with a severe respiratory illness and renal failure in a London intensive care unit and a 60-year-old Saudi Arabian man who was infected with a virtually identical virus who died in June.The identification of a new coronavirus has raised global health worries, because a then-novel one in 2003 caused the SARS epidemic that sickened 8,422 people, killing 916 of them. Health officials have said the new virus is clearly different than the one that caused SARS, and some have said that an animal source can’t be excluded.See also:Sep 27 HPA updateSep 27 CHP statementSep 26 HPA algorithm for investigating possible novel coronavirus infectionsSep 26 HPA algorithm for investigating close contacts of confirmed casesSep 26 HPA infection control advice
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scansResearchers develop a rapid test for antibiotic susceptibilityOriginally published by CIDRAP News Aug 10A team of researchers in Sweden have developed a test that can determine antibiotic susceptibility in less than 30 minutes, according to a new study in Proceedings of the National Academy of Sciences.The “fASTest” method, developed by researchers at Uppsala University, uses a microfluidic chip that captures bacterial cells in 2,000 parallel cell traps. Growth media containing antibiotics is loaded into the chip, and the growth rate of the individual bacterial cells in response to the antibiotic is monitored using microscopy and compared to the growth rate of cells exposed to growth media without antibiotics. The total time for testing, from loading of the bacterial sample to diagnostic readout, is less 30 minutes—fast enough to be used at the point of care.For the study, the researchers tested urinary tract infections (UTIs) caused by Escherichia coli, the primary cause of infection in 85% of UTIs diagnosed in primary care. First, they determined the antibiotic response time of E coli to nine different antibiotics used to treat UTIs, and found that it was possible to detect changes in the growth rate of the bacteria within 3 to 11 minutes. In a test of 49 clinical uropathogenic E coli isolates in response to ciprofloxacin, all isolates were correctly classified as susceptible or resistant in less than 10 minutes, with similar sensitivity and specificity as traditional methods of antibiotic susceptibility tests.Although the test is years away from clinical use, the findings are significant because traditional antibiotic susceptibility tests, which measure bacterial growth with and without antibiotics in liquid cultures or solid agar plates, typically take 1 to 2 days to produce results. As a result, clinicians often have to prescribe a broad-spectrum antibiotic in the early stages of an infection, or risk prescribing the incorrect antibiotic. A susceptibility test that could provide results in 30 minutes would enable clinicians to provide proper treatment more quickly.”The hope is that, in the future, the method could be used in hospitals and health centers to quickly provide correct treatment and reduce unnecessary use of antibiotics,” study co-author Dan Andersson, PhD, said in an Uppsala University news release.Aug 8 Proc Natl Acad Sci studyAug 8 Uppsala University news release New antibiotic shows promise against gonorrhea in lab experimentsOriginally published by CIDRAP News Aug 9New early-stage research out of the United Kingdom has identified a potential antibiotic candidate for treatment of drug-resistant gonorrhea.In a paper published in Antimicrobial Agents and Chemotherapy, scientists from the London School of Hygiene and Tropical Medicine and Imperial College London report that the novel antimicrobial closthioamide (CTA) inhibited the growth of 146 of 149 (98%) clinical Neisseria gonorrhea isolates at a minimum inhibitory concentration of 0.125mg/L or less, a low therapeutic dose that could reduce any potential toxicity. Furthermore, the in vitro tests showed CTA to be effective against N gonorrhea isolates that were resistant to ciprofloxacin and to the first-line antibiotics ceftriaxone and azithromycin.CTA, discovered in 2010, is derived from the anaerobic bacterium Clostridium cellulolyticum. It has been shown to have high in vitro activity against other drug-resistant microorganisms, including multidrug-resistant (MDR) bacteria.The emergence of gonorrhea strains that are resistant to azithromycin and ceftriaxone—the currently recommended treatments for the sexually transmitted infection—is a major concern for public health officials, since there are no other alternatives. Last month, the World Health Organization warned that widespread treatment failure is likely in the coming years unless new antibiotics are developed. Serious and permanent health problems, including pelvic inflammatory disease and infertility, can result if gonorrhea goes untreated.The authors of the study say that while the initial laboratory results are intriguing, further research in animals and humans is needed to evaluate CTA’s safety and effectiveness.”Despite showing tremendous promise, it will be a number of years before, and if, we can use the drug in real life human cases,” lead author John Heap, PhD, said in a news release from Imperial College London.Aug 7 Antimicrob Agents Chemother abstractAug 7 Imperial College London news release Rapid malaria diagnostic tests linked to increased antibiotic prescribingOriginally published by CIDRAP News Aug 8A review of 10 linked studies yesterday in the American Journal of Tropical Medicine and Hygieneindicates that introduction of rapid diagnostic tests for malaria in Africa and Afghanistan curbed use of anti-malaria drugs but was also linked to increased antibiotic prescribing.The 10 related studies, which analyzed drug prescriptions written from 2007 to 2013 for 562,368 patients in malaria-endemic regions of Africa (Ghana, Cameroon, Tanzania, Nigeria, and Uganda) and Afghanistan, were conducted by the ACT Consortium, a research partnership created to investigate delivery of artemisinin-based combination therapies (ACTs) for malaria treatment. The studies looked at the impact of malaria rapid diagnostic testing (mRDT) on fever case management across a range of clinical settings, and included a comparison group without mRDT intervention.Overall, mRDTs were associated with lower ACT prescribing, with mRDT interventions in most settings (10 African settings, 4 Afghanistan settings) producing statistically significant reductions in ACT prescribing compared to scenarios without mRDT intervention. Lower prescribing was mostly due to malaria test-negative patients not receiving ACTs. However, mRDT interventions were also associated with significantly more systemic prescribing of antibiotics in seven settings (5 in Africa, 2 in Afghanistan), with antibiotics being prescribed to 40% to 80% of patients who tested negative.Across most settings, either an antimalarial or an antimicrobial was prescribed for more than 75% of patients. The studies also showed that prescribing did not always adhere to malaria test results. In many settings, ACTs were prescribed to more than 30% of test-negative patients; in other settings, more than 20% of the patients who tested positive were not given ACTs.The findings echo those from a Mar 29 BMJ analysis of nine of the studies, which found that the risk of antibiotic prescription was 21% higher in places where mRDT was introduced. The authors say the results “highlight issues that warrant particular attention in future work on point-of-care diagnosis and fever and malaria case management.Aug 7 Am J Trop Med Hyg abstractRelated Mar 29 CIDRAP News story Study: Carbapenem restriction reduces resistance in P aeruginosaOriginally published by CIDRAP News Aug 8A new study in Clinical Infectious Diseases suggests that restricting carbapenem antibiotics, even for a short time, may be an effective strategy for managing carbapenem resistance in Pseudomonas aeruginosa.In the study, researchers at King Saud Medical City, a public hospital in Riyadh, Saudi Arabia, conducted a two-phase retrospective study to investigate to compare the antimicrobial susceptibility pattern of P aeruginosa before and after implementation of a carbapenem restriction program. The program was in response to the identification of a new strain of P aeruginosa in the hospital’s intensive care unit that was susceptible to many antipseudomonals but resistant to imipenem and meropenem.The program restricted use of imipenem and meropenem except in three cases: culture-based carbapenem therapy, empirical carbapenem therapy after failure of other antibiotics, and carbapenem therapy prescribed by an infectious disease consultant. The first phase of the study was from May 2016 to July 2016 (before carbapenem restriction) and the second phase was September 2016 to November 2016 (after carbapenem restriction).The results showed that after implementing carbapenem restriction, overall carbapenem consumption fell from 28.44 to 11.67 defined daily doses (DDD) per 1,000 patient days, and the percentage of P aeruginosa isolates that were resistant to imipenem and meropenem decreased significantly, from 76% to 38.5% (P=0.019) and from 74.1% to 30% (P=0.012), respectively. Susceptibility of P aeruginosa to other antibiotics was not affected by carbapenem restriction. The study did not investigate clinical outcomes before and after carbapenem restriction.The authors write, “Although some investigatorsargued that a long period of time is required for a change in antibiotic prescribing practice to show an effect on the antimicrobial susceptibility pattern, the present study proved that even a short duration of change in antibiotic prescribing habits might cause a change in the antimicrobial susceptibility pattern.”Aug 4 Clin Infect Dis study Study shows clinical impact of an educational ASP in SpainOriginally published by CIDRAP News Aug 8A new study by researchers in Spain reports that an education-based antimicrobial stewardship program (ASP) at a large teaching hospital produced a sustained reduction in antibiotic use and decreased the incidence and mortality of hospital-acquired candidemia and multidrug-resistant bloodstream infections (MDR-BSI).The quasi-experimental study, published yesterday in Clinical Infectious Diseases, investigated to impact of a multifaceted educational intervention at a tertiary-care teaching hospital in Sevilla, Spain, over a 5-year period. The main intervention was weekly peer-to-peer educational interviews, in which counselors selected one antibiotic prescription per week and interviewed the prescribers about the case. The researchers recorded data on antibiotic consumption over five years, calculated as DDD per 1,000 occupied bed days (OBD), and analyzed the incident density per 1,000 OBD of hospital-acquired BSI caused by the six most frequent microorganisms—E coli, Klebsiella pneumoniae, Acinetobacter baumannii, P aeruginosa, Staphylococcus aureus, and Candida SPP. They also assessed crude death rate per 1,000 OBD.The results showed that implementation of the ASP was followed by a significant drop in antibiotic consumption that was sustained during the following years, with the median consumption dropping from 1,008 DDD/1,000 OBD in the first year to 774 DDD/1,000 OBD in the last year. The reduction was observed in all classes of antibiotics.In addition, the incidence density and mortality of hospital-acquired candidemia and MDR-BSI decreased parallel to the reduction in antibiotic pressure. The increasing trend observed in the pre-intervention period for incidence of candidemia and MDR-BSI (+0.018 cases per 1,000 OBD per quarter) reverted toward a decreasing trend with a change in slope of -0.029 cases/1,000 OBD per quarter, while the increasing trend in the crude death rate in the pre-intervention period (+0.011 deaths/1,000 OBD per quarter) reverted toward a decreasing trend with a change in slope of -0.015deaths/1,000 OBD per quarter.The authors of the study say they believe this is the first ASP to demonstrate that reducing antibiotic pressure can reduce the incidence and mortality of hospital-acquired MDR-BSI, an important finding given that the evidence supporting the clinical benefits of ASPs has to date been insufficient. “Our results prove that educational interventions can be successful when based on active learning targeted towards real clinical problems of interest to specialists of all departments,” they write.Aug 7 Clin Infect Dis abstract Study: Macrolide-resistant M pneumoniae on the decline in JapanOriginally published by CIDRAP News Aug 7A new study in Emerging Infectious Diseases reports that the prevalence of macrolide-resistant Mycoplasma pneumoniae in Japan was as high 82% in 2012 but has declined in the following years.In the study, Japanese researchers investigated 1,448 nasopharyngeal swab samples and sputum samples from children who were treated for respiratory tract infections caused by M pneumoniae from January 2008 through December 2015. In general, M pneumoniae infection is a mild illness that is most common in young adults and school-aged children; outbreaks tend to occur mostly in crowded environments, like schools. An M pneumoniae pandemic occurred in Japan during 2010-2012, especially among children, and a rise in macrolide-resistant infections has been documented during that pandemic. The purpose of the study was to investigate macrolide resistance after the pandemic.The researchers found that the overall prevalence rate of the macrolide-resistant M pneumoniae during the study period was 70.2% (1,016 of 1,448 samples). When divided into three time periods (pre-pandemic, pandemic, and post-pandemic), the overall rate of macrolide-resistant M pneumoniae was substantially lower in the post-pandemic period than in the pandemic period. After a peak of 81.6% in 2012, macrolide-resistant M pneumoniae decreased to 65.8% in 2013, 59.3% in 2014, and 43.6% in 2015.By comparison, the prevalence of macrolide-resistant M pneumoniae infections is 13.2% in the United States, 8.3% in France, and 3.1% in Germany, which could reflect differences in macrolide prescribing among countries. The authors of the study say careful, continuous monitoring of macrolide-resistant M pneumoniae infection rates in Japan and other countries is needed.Aug 4 Emerg Infect Dis dispatch
East Hampton, NY – 10/17/18 – East Hampton boys soccer vs. Amityville in East Hampton, NY October 17, 2018. Independent/Gordon M. Grant East Hampton, NY – 10/17/18 – East Hampton boys soccer vs. Amityville in East Hampton, NY October 17, 2018. (Photo by Gordon M. Grant) East Hampton, NY – 10/17/18 – East Hampton boys soccer vs. Amityville in East Hampton, NY October 17, 2018. (Photo by Gordon M. Grant) East Hampton, NY – 10/17/18 – East Hampton boys soccer vs. Amityville in East Hampton, NY October 17, 2018. (Photo by Gordon M. Grant) Share East Hampton’s Aubrey Tulp tries to win a header. Independent/Gordon M. GrantEast Hampton’s boys soccer team had high expectations for this season.The Bonackers, boasting seven seniors, were predicted to finish second in a competitive League V. East Hampton may have finished 7-7 in a third-place tie with Wyandanch and Islip, and lost to No. 1 Amityville (in League V and Class A) in the final game of the regular season, 4-0, but the team made it back to the first round of the playoffs.East Hampton fell to Hauppauge in a tough 2-1 fashion last year. No. 11-seeded East Hampton edged No. 6 Kings Park October 22, 1-0, to avenge a first-round loss from last season. Sebastian Fuquen scored the lone goal of the game in the second half. Kurt Matthews made six saves for the Bonackers, which travel to square off against No. 3 Elwood-John Glenn in the quarterfinals October 25 at 2 PM.Also making it to the postseason are Class B contenders Mattituck and Hampton Bays. The No. 3 Tuckers take on No. 2 Center Moriches on the road on Wednesday, October 24, at 2:30 PM, and the Baymen travel to No. 1 Babylon at 4:30 PM. Mattituck finished 10-6 overall and 9-3 in League VII behind undefeated Babylon (12-2-1 overall, 12-0 in the conference). Hampton Bays (6-8-1 overall, 4-7-1 in League VI) finished fourth. Center Moriches ended the season 10-4-2 and 8-3-1 in conference play. The winners of the semifinal matchups will play each other in the Class B final at Diamond in the Pines in Coram on Saturday at 1 PM. Greenport, which ended the season 10-6 overall and 8-4 in League VIII, earned the No. 1 seed and a chance to face No. 2 Southold (8-7 and 7-5 in League VII) in the Class C final at Diamond in the Pines on Saturday, October 27, at 1 PM. The Porters edged Southold 2-1 in the final game of the regular season for both teams October 16. Mateo Arias scored both goals and William Chapeton had an assist. The game-winner was off a free kick from 23 yards out in the second half. Greenport’s Miguel Torres and Southold’s Cole Brigham each made five stops in firstname.lastname@example.org
The British Marine Aggregate Producers Association (BMAPA) has been working on a series of regional brochures to describe the geological evolution of local coastlines, the geological origins of the offshore sand and gravel resources that are being dredged and the influence of the modern day waves and tides on both these deposits and the coastline.Mark Russell, Director BMAPA, said, “With the growing influence of climate change and extreme weather events, the profile and awareness of local coastal change has never been higher. This can sometimes lead to the view that such changes are somehow being influenced by the extraction of marine sand and gravel, despite the fact that dredging takes place in licensed areas well offshore and there are no physical processes that link it to the natural erosion of the coastline that has been occurring since prehistory.”“Rather than representing a threat to coastlines, the marine aggregate sector plays a key strategic role responding to the challenges of natural coastal change by supplying sand and gravel to large scale coast defense and beach replenishment projects, with over 38 million tonnes being used for this purpose since 1990. Given the dual challenges presented by sea level rise and increased storminess, the use of marine sand and gravel for coast protection purposes is likely to become increasingly important – a fact recognized by both the Marine Policy Statement and the developing marine planning process.”Information is also provided about the scale of marine aggregate dredging that is taking place, how the activity is assessed, regulated and monitored and how similar activities are controlled in other European countries.In preparing these brochures, BMAPA and The Crown Estate liaised closely with representatives of the Local Government Association Coastal Special Interest Group (LGA Coastal SIG).Half the construction aggregates currently being used in London come from marine sources. With on average three 5,000 tonne cargoes a day being landed at wharves along the Thames river.More Info
To continue enjoying Building.co.uk, sign up for free guest accessExisting subscriber? LOGIN Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.Limited access to building.co.ukBreaking industry news as it happensBreaking, daily and weekly e-newsletters Get your free guest access SIGN UP TODAY Subscribe to Building today and you will benefit from:Unlimited access to all stories including expert analysis and comment from industry leadersOur league tables, cost models and economics dataOur online archive of over 10,000 articlesBuilding magazine digital editionsBuilding magazine print editionsPrinted/digital supplementsSubscribe now for unlimited access.View our subscription options and join our community Subscribe now for unlimited access
Ovens has spent 35 years in the freight industry, holding a variety of positions spanning sales and business development, HR and operations in Europe, the Middle East and Indian subcontinent. He has worked for several major organisations including Panalpina and Danzas, and was most recently employed as senior VP Contract Logistics for Kuehne & Nagel.In his new post at TGF, Ovens will oversee all sales and business development throughout the company’s European and Middle East stations, co-ordinating national sales forces and ensuring EME sales’ contribution to the TGF global sales strategy.
Author: Associated Press Do you see a typo or an error? Let us know. SHARE NEW YORK (AP) – Yahoo says it believes hackers stole data from more than one billion user accounts in August 2013, in what is thought to be the largest data breach at an email provider.The Sunnyvale, California, company was also home to what’s now most likely the second largest hack in history, one that exposed 500 million Yahoo accounts . The company disclosed that breach in September. Yahoo said it hasn’t identified the intrusion associated with this theft.Yahoo says the information stolen may include names, email addresses, phone numbers, birthdates and security questions and answers. The company says it believes bank-account information and payment-card data were not affected.But the company said hackers may have also stolen passwords from the affected accounts. Technically, those passwords should be secure; Yahoo said they were scrambled twice – once by encryption and once by another technique called hashing. But hackers have become adept at cracking secured passwords by assembling huge dictionaries of similarly scrambled phrases and matching them against stolen password databases.That could mean trouble for any users who reused their Yahoo password for other online accounts.QUESTIONS FOR VERIZONThe new hack revelation raises fresh questions about Verizon’s $4.8 billion proposed acquisition of Yahoo, and whether the big mobile carrier will seek to modify or abandon its bid. If the hacks cause a user backlash against Yahoo, the company’s services wouldn’t be as valuable to Verizon. The telecom giant wants Yahoo and its many users to help it build a digital ad business.In a statement, Verizon said that it will evaluate the situation as Yahoo investigates and will review the “new development before reaching any final conclusions.” Spokesman Bob Varettoni declined to answer further questions.Yahoo said Wednesday that it is requiring users to change their passwords and invalidating security questions so they can’t be used to hack into accounts. More than 1 billion Yahoo accounts hacked Published: December 14, 2016 5:11 PM EST Updated: December 14, 2016 6:07 PM EST
A man detained under the Mental Health Act for attempted murder and who had threatened to kill his solicitor had no right to be left alone with lawyers when on trial for a further attempted murder, the Court of Appeal has ruled. In Regina v Edward Brown (formerly Latham) the court heard an appeal against a conviction on the grounds of a Crown court ruling that the defendant’s conferences with his lawyers be conducted in the presence of two nurses. Brown was sentenced to life imprisonment for the attempted murder of a fellow patient at Rampton hospital in Nottinghamshire, where he was already serving life sentences for attempted murder, with a weapon fashioned from a radio aerial. The judge in the case had ruled that, as there were no facilities at court to screen defence counsel from their clients, Brown, described as an ‘exceptionally dangerous individual’, must be shackled to a minimum of two nurses when in direct personal contact with a third party.Brown’s appeal argued that the ruling breached his right at common law to consult privately with his lawyers and his ‘fair trial’ right under article 6 of the European Convention on Human Rights. Dismissing the appeal, the Rt Hon Lord Justice Fulford, the Honourable Mr Justice Holroyd and the Honourable Mr Justice Singh ruled that the inviolable nature of legal professional privilege does not apply if communications are used for an improper purpose – in this case for the defendant to harm himself or his lawyers. The judgment also notes there was no suggestion that any misuse was made of overheard communications. ‘Nurses deployed to ensure that someone who is detained does not harm himself (or others) are not to be equated with investigating police officers,’ the judgment states. On the ECHR argument, the judges ruled that the right to confidential communications with lawyers is not absolute. ‘Instead, it can be restricted for good reason and one of those reasons is if the individual’s life is at risk.’Therestrictions on Brown ‘were a proportionate and appropriate response to the grave threat the appellant posed to himself and we do not accept that they rendered the proceedings unfair’.A Law Society spokesperson said: ‘This is an interesting decision in a narrow and rare set of circumstances. We will monitor how this judgment is interpreted. Legal professional privilege is a precious human right, tested and refined by centuries of common law.’